The November 2022 Special Issue of Preventive Medicine is now available. The ninth in a series that focuses on behavior change, health, and health disparities, this issue includes select research in the field of tobacco control and regulatory science. VCBH Director Stephen Higgins, PhD organized the selection of papers and acted as guest editor.

Racial minorities and people with lower incomes or who are insured by Medicare or Medicaid are significantly less likely to receive the most advanced therapies and more likely to die after suffering a pulmonary embolism, according to a new analysis conducted by University of Vermont Professor of Medicine Mary Cushman, M.D., M.Sc., and colleagues.

(DECEMBER 17, 2022) Neuropsychologist Sharon Leach, Ph.D., and child psychiatrist Feyza Basoglu, M.D., both clinical assistant professors of psychiatry, will challenge participants to diagnose psychiatric or neurological disorders as part of the 14th annual Vermont Brain Bee neuroscience competition to be held at the Larner College of Medicine on February 11, Seven Days reports.

(DECEMBER 16, 2022) A Pfizer RSV vaccine for pregnant women is in phase 3 trial, with the potential to help infants cope with the sometimes serious illness, according to WCAX-TV. “If infants can be born with some immunity,” says pediatric critical care physician Rebecca Bell, M.D., associate professor of pediatrics, “even if it’s short-lived, even if it’s six months or one year, that can make a huge difference in terms of kids’ health.” (Click headline for more.)

(December 15, 2022) At Vascular InterVentional Advances 2022 in Las Vegas, Daniel Bertges, M.D., professor of surgery, presented promising interim data from a study of the effectiveness of the IN.PACT Admiral drug-coated balloon in treating femoropopliteal in-stent restenosis.